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The Hippo pathway plays major roles in develop-
ment, regeneration, and cancer. Its activity is tightly
regulated by both diffusible chemical ligands and
mechanical stimuli. The pathway consists of a series
of kinases that can control the sub-cellular localiza-
tion and stability of YAP or TAZ, homologous tran-
scriptional co-factors. Caveolae, small (60–100 nm)
bulb-like invaginations of the plasma membrane,
are comprised predominantly of caveolin and cavin
proteins and can respond to mechanical stimuli.
Here, we show that YAP/TAZ, the major transcrip-
tional mediators of the Hippo pathway, are critical
for expression of caveolae components and there-
fore caveolae formation in both mammalian cells
and zebrafish. In essence, without YAP/TAZ, the
cell loses an entire organelle. CAVEOLIN1 and
CAVIN1, the two essential caveolar genes, are direct
target genes of YAP/TAZ, regulated via TEA domain
(TEAD) transcription factors. Notably, YAP/TAZ
become nuclear enriched and facilitate target gene
transcription in cells with diminished levels of caveo-
lae. Furthermore, caveolar-mediated shear stress
response activates YAP/TAZ. These data link caveo-
lae to Hippo signaling in the context of cellular
responses to mechanical stimuli and suggest activ-
ity-based feedback regulation between components
of caveolae and the outputs of the Hippo pathway.
INTRODUCTION
The Hippo pathway is involved in multiple developmental and
regenerative processes, such as tissue renewal of the liver,
heart, kidney, intestine, and lung. The Hippo pathway needs to
be tightly and dynamically regulated, as otherwise hyperactive
yes-associated protein/transcriptional co-activator with PDZ-
binding motif (YAP/TAZ) cause disease, most notably cancer
[1–5]. The pathway comprises an upstream inhibitory serine-Current Biology 29, 1–14, Ja
This is an open access article undthreonine kinase cascade that ultimately activates large tumor
suppressor kinase (LATS)1/2, which in turn phosphorylates and
thereby inhibits the co-transcriptional regulators YAP/TAZ
through cytoplasmic sequestration as well as protein degrada-
tion [6, 7]. The pathway is regulated by both soluble ligands
andmechanical stimuli, where the cytoskeleton and Rho-guano-
sine triphosphatases (GTPases) play central roles in mediating
these responses [7, 8]. Importantly, how mechanical signals
are sensed at the plasma membrane and transduced via the
Hippo pathway is currently not well understood.
Caveolae, meaning little caves, are multifunctional organelles
localized in the plasma membrane and have mechanotrans-
ductive and protective roles [9–15]. They are generated by
CAVEOLIN1–3 (CAV1–3) and CAVIN1–4 (also known as PTRF,
SDPR, PRKCDBP, and MURC) as well as Eps15 homology
domain (EHD) and PACSIN2 proteins [16, 17]. CAV3 and CAVIN4
are muscle-specific caveolar proteins [16, 17]. CAV1 is essential
for caveolae formation in non-muscle cells, whereas CAVIN1 is
critical for caveolae formation in all cells [18–21].
As both the Hippo pathway and caveolae are regulated by
mechanical stimuli, such as shear stress, we sought to investi-
gate whether the Hippo pathway and caveolae are functionally
integrated in this process.
RESULTS
YAP/TAZ Drive Caveolar Protein Expression
We utilized genome-edited YAP/TAZ double knockout (Y/T KO)
and LATS1/2 double knockout (L1/L2 KO) HEK293A cells [22]
and compared these to wild-type (WT) HEK293A cells to
examine whether the activity state of YAP/TAZ regulates caveo-
lar protein expression. There was a dramatic reduction in
CAVEOLIN and CAVIN protein expression in the Y/T KO cells
(Figures 1A, 1B, 1D–1F, and S1A–S1C). This effect was mirrored
in an additional Y/T KO clone (Figures S2A, S2B, and S2E). More-
over, caveolar proteins were markedly increased in L1/L2 KO
cells (Figures 1A and 1C–1F), where YAP/TAZ are hyperactive,
as evident from increased YAP/TAZ nuclear localization (Figures
1A, 1C, S1B, and S1F) and dephosphorylated YAP status (Fig-
ures 1F, 1G, and S2E). Re-introduction of LATS1 into L1/L2 KO
cells, but not a kinase dead version, increased YAP phosphory-
lation and decreased CAVIN1, CAV1, and CYR61 expressionnuary 21, 2019 ª 2018 The Author(s). Published by Elsevier Ltd. 1
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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biogenesis, CAV1 and CAVIN1, therefore mirrored the expres-
sion of the well-characterized YAP/TAZ target gene CYR61 [7]
(Figures 1F, S2E, and S2G). To determine whether the ability
for caveolar protein expression was due to a cell-intrinsic depen-
dence on YAP/TAZ and not merely mediated by paracrine ef-
fects, we utilized a mixed cell population immunofluorescence
(IF)-based assay. Due to the specificity of the antibodies used
(Figure S1A), the assay allowed for direct comparison between
Y/T KOcells andWT cells in terms of the CAV1 or CAVIN1 protein
levels (Figures 1H–1L, S1D, S1E, S2C, and S2D). CAV1 and
CAVIN1 protein expression, as well as CAV2 (Figure 1M), was
directly dependent on YAP/TAZ cell-intrinsic expression (Figures
1H–1L). Importantly, upon exogenous plasmid-based re-expres-
sion in Y/T KO cells, CAV1 and CAVIN1 could be found co-
localizing within plasma membrane domains (Figure S3A). This
localization is comparable to that of endogenous CAV1 and
CAVIN1 in WT cells (Figure S3B). These data show that YAP/
TAZ are required for the expression of the essential caveolar pro-
teins CAVIN1 and CAV1.
CAV1 and CAVIN1 Are Direct YAP/TAZ-TEAD Target
Genes
As YAP/TAZ are transcriptional co-activators, we explored the
possibility that the essential role of YAP/TAZ in caveolar protein
expression was due to transcriptional regulation. We compared
mRNA levels from HEK293A Y/T KO and L1/L2 KO to WT cells
(Figures 2A and 2B). In L1/L2 KO cells, with hyperactive YAP/
TAZ, there was an increase in the well-established YAP/TAZ
target genesCYR61 andCTGF [23, 24] as well as ofCAVIN1 (Fig-
ures 2A and 2B), an effect that was paralleled by exogenously
expressing hyperactive YAP (Figure S2J). Re-introduction of
LATS1, but not a kinase dead version of LATS1, in L1/L2 KO cells
lowered the expression of CYR61, CTGF, CAV1, and CAVIN1
(Figure S2I). In addition, there was a striking absence of CAV1
and CAVIN1 mRNA expression as well as of CYR61 and CTGF
in Y/T KO cells (Figures 2A, 2B, and S2F). As YAP/TAZ bind
TEAD transcription factors [24–28], we treated cells with verte-
porfin, an inhibitor of the YAP-TEAD interaction [29]. This re-
sulted in a diminished expression of CYR61, CTGF, CAV1, and
CAVIN1 (Figure 2C). The binding of YAP to TEAD is partly formedFigure 1. YAP/TAZ Are Necessary for Caveolar Protein Expression
(A) Confocal images of wild-type (WT) HEK293A cells labeled for DAPI (blue), YA
(B and C) YAP/TAZ KO cells (Y/T KO) (B) and LATS1/2 KO (L1/L2 KO) (C) labeled
Scale bars (A–C) represent 30 mm. (A)–(C) are related to Figures S1A–S1C, S1F,
(D) Dot plot of quantified CAV1 levels from images, as shown in (A)–(C). In Y/T K
Means ± SEM.
(E) Dot plot of CAVIN1 levels from images as shown in Figure S1B. Means ± SEM
(F) Western blots from Y/T KO, WT, and L1/L2 KO HEK293A cells (Figures S2E a
(G) PhosTag gel-based western blots probed against YAP from cell lysates as in
(H) Mixed cell culture of Y/T KO and WT HEK293A cells were fixed and labeled f
cells. Note, cells with no YAP/TAZ signal have low CAV1 signal. Scale bar repres
(I) Close up of cells from red box in (H).
(J) Dot plot of CAV1 levels in mixed cell populations of Y/T KO and WT cells ana
(K) Mixed cell population as in (H) labeled for YAP/TAZ (red), CAVIN1 (green),
Figure S1D.
(L) Dot plot of CAVIN1 levels in mixed populations of Y/T KO and WT cells carrie
(M) Cells as in (H), labeled for YAP (green), CAVEOLIN2 (CAV2) (red), and DAPI (
Scale bars in (I), (K), and (M) are 15 mm. Further related is Figures S7N–S7R.via critical hydrogen bonds to serine94 in YAP [24–26]. We stably
expressed either vector, WT, or S94A YAP into Y/T KO cells and
assessed caveolar protein expression in these cells (Figure 2D).
Only WT YAP was able to induce expression of CYR61, CAV1,
and CAVIN1 (Figure 2D). We again utilized the IF-based mixed
culture assay, which revealed that CAV1 and CAVIN1 expression
was restored in Y/T KO cells in a cell-intrinsic manner by the
re-expression of WT YAP, but not by expression of the TEAD-
binding-deficient S94A YAP (Figures 2E–2J). To establish
whether this was indeed due to transcriptional regulation, we
performed qPCR analysis of samples prepared from Y/T KO
cells expressing WT or S94A YAP. There was a significant upre-
gulation of CAV1 and CAVIN1 expression upon re-expression of
WT YAP (Figure 2L). To assess whether TAZ was similarly
capable of inducing CAV1 and CAVIN1 expression in Y/T KO
cells, we introduced either WT TAZ or a TEAD-binding-deficient
TAZ mutant (S51A). Similar to YAP, exogenous TAZ expression
induced CAV1 and CAVIN1 expression in the Y/T KO back-
ground in a cell-intrinsic and TEAD-binding-dependent manner
(Figures 2K, 2M, S3E, and S3F). This apparent dependence on
YAP/TAZ-TEAD interaction prompted us to analyze the role of
TEADs in the expression of CAV1 and CAVIN1. We therefore
established cells with short hairpin (sh)-mediated knockdown
of TEADs. A clear TEAD dependence was evident for the expres-
sion of CAV1 and CAVIN1 (Figures 3A–3F and S4A–S4F).
To determine whether TEAD proteins can localize to CAVIN1
and CAV1 promoters, we examined their proximal genomic
regions for TEAD recognition motifs (Figure S4G). When a
genomic region of CAV1 (1,907 to +200 bp) or CAVIN1
(1,250 to +150 bp) was inserted into a plasmid upstream of a
luciferase open reading frame, expression of YAP increased
luciferase activity (Figure 3G). In contrast, a shortCAV1 genomic
region that does not harbor TEAD recognitionmotifs (Figure S4G)
had no effect on the luciferase activity (Figure 3G).
To examine whether this interaction also takes place in vivo,
we carried out chromatin immunoprecipitation (ChIP) assays
with antibodies against TEAD1. Regions of both CAVIN1 and
CAV1 proximal promoters, which contain the consensus binding
sequence for the YAP/TAZ-TEAD transcriptional complex, were
enriched by antibodies targeting TEAD1 (Figure 3H). To test
whether YAP also localized to these regions, we carried outP/TAZ (red), and CAVEOLIN1 (CAV1) (green).
and imaged as cells in (A).
and S2A–S2D.
O (red), WT (black), and L1/L2 KO (blue) cells, each dot represents one cell.
.
nd S2G). GAPDH and HSP90 serve as loading controls.
(F) (Figure S2H).
or YAP/TAZ (red), CAV1 (green), and DAPI (blue). Arrows: examples of Y/T KO
ents 30 mm.
lyzed in images as shown in (H). Each dot represents one cell. Means ± SEM.
and DAPI (blue). Arrows: examples of Y/T KO cells. Zoomed-out image is in
d out on images as shown in (K). Means ± SEM.
blue). Zoomed-out image is in Figure S1E. Arrows: examples of Y/T KO cells.
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Figure 2. CAV1 and CAVIN1 Expression Depend on YAP/TAZ-TEAD Interaction
(A) qPCR analysis of established YAP/TAZ targets. mRNA from Y/T KO and L1/L2 KO HEK293A cells compared to WT HEK293A cells (Figures S2F and S2I).
Means ± SD.
(B) qPCR data as in (A), analyzed for the expression of CAV1 and CAVIN1 (Figures S2F and S2I). Means ± SD.
(C) Verteporfin-treated WT HEK293A cells analyzed by qPCR. Inhibition of the interaction between YAP-TEAD reduces expression of caveolar genes.
Means ± SD.
(legend continued on next page)
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dependent manner, regions in both the CAVIN1 and CAV1
promoters were enriched by antibodies targeting YAP (Figures
3I and 3J). These experiments indicate that the TEAD-YAP com-
plex physically binds to promoters of both essential caveolar
genes, CAVIN1 and CAV1.
To explore whether regulation of CAVIN1 and CAV1 expres-
sion by YAP/TAZ-TEAD is a general phenomenon, we used
data from cancer cell line encyclopedia (CCLE) [30] and con-
ducted pairwise bioinformatic analysis of CYR61 and CTGF,
CAVIN1, or CAV1 expression, respectively (Figure 4A). A strong
positive correlation between the well-established YAP/TAZ-
TEAD target genes CTGF/CYR61 as well as for CAV1/CYR61
and CAVIN1/CYR61 was apparent. However, there was no cor-
relation between expression of CYR61 and FLOTILLIN2 (FLO2),
another plasma membrane protein [31], or HPRT1, a house-
keeping gene (Figure 4A).
These data show that YAP/TAZ regulate caveolar genes and
induce TEAD-mediated CAV1 and CAVIN1 gene expression
and that CAV1 and CAVIN1 are direct transcriptional targets of
this complex.
YAP/TAZ Activity Dictates Caveolar Protein Levels
To investigate whether the YAP/TAZ-TEAD transcriptional com-
plex is essential for the expression of CAV1 and CAVIN1 in other
cells, we chose the osteosarcoma cell line U2OS. U2OS cells
express high levels of the YAP/TAZ-TEAD target genes CTGF
and CYR61 as well as high levels of CAV1 and CAVIN1 (Fig-
ure S5A). Importantly, although YAP and TAZ are predominantly
nuclear in unstimulated U2OS cells, they do have a functional
Hippo pathway [23]. We attempted generating YAP/TAZ KO
U2OS cells but were unsuccessful, potentially due to essential
YAP/TAZ roles for cell survival in this cancer cell line. We there-
fore generated genome-edited single YAP and TAZ KO cell lines
(Figure S5D) with either knockdown of TAZ (shTAZ) or of YAP
(shYAP) (Figures 4B and 4C). In U2OS cells, as in HEK293A cells,
loss of YAP and TAZ resulted in loss of CAV1 and CAVIN1
expression (Figures 4B, 4C, and S5B).
Neurofibromatosis type 2 (NF2) (also known as merlin) [1–4] is
the most common mutated Hippo pathway tumor suppressor
gene. NF2 acts as an upstream activator of the kinase cascade
and therefore as an inhibitor of YAP/TAZ [6, 7]. We deleted
NF2 by CRISPR genome editing in U2OS cells to investigate
whether this would increase CAVIN1 and CAV1 expression. As(D) Western blots of lysates from Y/T KO cells stably re-expressing either control
exposure. Note, re-expression ofWT YAP, but not S94Amutant, deficient in TEAD
target genes, CYR61 and LATS2.
(E and F) Mixed population of Y/T KO cells expressingmyc-tagged YAP or empty v
S94A YAP or empty vector and labeled for myc (red), CAV1 (green), and DAPI (b
(G andH)Mixed cell culture of Y/T KO cells expressing either vector control ormyc
vector control or myc-tagged S94A YAP (H). Myc (red), CAVIN1 (green), and DA
Arrows in (E)–(H) highlight examples of myc-YAP-expressing cells. Scale bars (E
CAVIN1.
(I) Dot plot of CAV1 levels from images, as shown in (E) and (F). Each dot repres
(J) Dot plot of CAVIN1 levels from images, as shown in (G) and (H). Each dot rep
(K) Dot plot of CAV1 levels from mixed Y/T KO cell population expressing vector
shown in Figures S3E and S3F.
(L andM) qPCR data frommyc-taggedWT or S94A YAP compared to vector cont
expressing Y/T KO cells levels (M). Means ± SD.predicted, this was indeed the case (Figure 4D). Analyzing NF2
KO cells by IF, it was evident that YAP/TAZ localization was
increased in the nucleus compared to WT U2OS cells (Figures
4E–4G). Re-introduction of NF2 into NF2-deficient U2OS cells
rescued the phosphorylation state and thus activity of YAP (Fig-
ures 4H and 4I), as well as the mRNA expression and protein
levels of CYR61, CAVIN1, and CAV1 (Figures 4I and 4J). To
examine whether this transcriptional regulation was mediated
via TEADs, we generated shTEAD, shYAP, and shTAZ NF2 KO
U2OS cell lines and compared those to controls (Figures 4K
and S5B). Consistent with previous results, the expression of
CAV1 and CAVIN1 was also dependent on TEADs in U2OS WT
cells (Figures S5B and S5C). These results demonstrate that
TEADs are required for expression of CAV1 and CAVIN1 in
U2OS as in HEK293A cells.
YAP/TAZ double KO is embryonic lethal in both mice [32, 33]
and zebrafish [34]. To explore whether YAP/TAZ regulation of
caveolar proteins is conserved across species and within cells
of a living organism, we analyzed 12-somite-stage Y/T KO zebra-
fish as well as age- and background-matched WT embryos. The
samples were processed for electron microscopy (EM), and we
quantified the abundance of epidermal caveolae. There was a
striking decrease in the abundance of epidermal caveolae in
Y/T KO embryos (Figures 4L–4N). To examine whether this
lack of caveolae was due to decreased transcriptional activity
of YAP/TAZ target genes, we examined the expression levels
of cavin1 and cav1 as well as of cyr61 and ctgf in whole fish em-
bryos (Figure 4O) and observed a substantial downregulation of
all four genes in Y/T mutant embryos. Cumulatively, these data
suggest that YAP/TAZ-TEAD activity is broadly critical for caveo-
lae expression within vertebrates.
CAVIN1 and CAV1 Regulate YAP/TAZ Activity
Although understanding of the external inputs and cell surface
components for the Hippo pathway is incomplete, in many con-
texts, Hippo signaling and its effectors are under feedback
control [7, 35]. With this premise and having established that
Hippo signaling directly regulates caveolar gene expression,
we investigated whether caveolae modulate the Hippo pathway.
We initially generated CAV1 knockdown U2OS cells. These cells
showed an upregulation of CTGF and CYR61 (Figures 5A, 5D,
and 5E) protein expression as well as a decrease in the inhibitory
pYAP-S127-phosphorylation (Figure 5A). The lowered protein
levels of the cavin proteins (CAVIN1 and CAVIN2), uponplasmid, myc-tagged WT, or S94A mutant YAP. l.e., long exposure; s.e., short
binding, restores expression of caveolar aswell as established YAP/TAZ-TEAD
ector (Figure S3C) or mixed population of Y/T KO cells expressingmyc-tagged
lue; F).
-tagged YAP (Figure S3D) or mixed cell culture of Y/T KO cells expressing either
PI (blue) are shown.
)–(H) represent 15 mm. Note, only YAP WT induces expression of CAV1 and
ents one cell. Means ± SEM.
resents one cell. Means ± SEM.
control and TAZ (WT) or TAZ (S51A) labeled for CAV1 and TAZ from images as
rol expressing Y/T KO cells (L) andWT or S51A TAZ compared to vector control
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Figure 3. CAV1 and CAVIN1 Are Direct YAP/TAZ-TEAD Target Genes
(A) Western blots of lysates from shTEADs and shCon HEK293A cells.
(B) Mixed cell population of shTEADs and shCon HEK293A cells labeled for DAPI (blue), CAV1 (red), and TEAD1 (green). Discrete cell populations are shown in
Figure S4A (see also Figure S4B).
(C) Mixed cell population of shTEADs and shCon HEK293A cells labeled for DAPI (blue), TEAD1 (red), and CAVIN1 (green). Discrete cell populations are shown in
Figure S4D.
Arrows in (B) and (C): examples of shTEADs cells. Scale bars in (B) and (C) represent 15 mm.
(D and E) Dot plot of CAV1 levels from images, as shown in (B) (Figure S4C; D) and dot plot of CAVIN1 levels from images, as shown in (C) (Figure S4E; E). Each dot
represents one cell. Means ± SEM.
(F) qPCR data from cells as in (A) (related to Figure S4F). Means ± SD.
(G) YAP drives CAVIN1 and CAV1 promoter activity. Luciferase reporters were generated carrying either a short (500 to +200 bp), or long (1,907 to +200 bp)
fragment of the CAV1 promoter region or a fragment (1,250 to +150 bp) of the CAVIN1 promoter region (related to Figure S4G). The reporters were introduced
into Y/T KO HEK293A cells together with either a YAP or a vector control plasmid. Note that only the long CAV1 form contains the predicted TEAD recognition
motifs. Means ± SD.
(H) Real-time PCR analysis of TEAD1 chromatin immunoprecipitation (ChIP) in HEK293A cells. The precipitated DNA was quantitated using primers specific for a
promoter region or a control in-gene (Ing) region. Data are means ± SD of triplicates from a representative experiment. Endogenous TEAD1 binds to both CAV1
and CAVIN1 promoters.
(I and J) YAP ChIP for CAV1 and CAVIN1 in shCon HEK293A cells (I) and in shTEADs HEK293A cells (J). Endogenous YAP binds to both CAV1 and CAVIN1
promoters in a TEAD-dependent manner.
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Current Biology (2018), https://doi.org/10.1016/j.cub.2018.11.066knockdown of CAV1, is most likely due to diminished stability
of cavin proteins in CAV1-deficient cells (Figures 5A, S6A,
and S6B), consistent with previous reports [18]. To investigate
whether the hyperactivity of YAP/TAZ was due to paracrine
effects, we generated mixed cell cultures of shCAV1 and
control cells and processed them in parallel for IF. Using anti-
bodies against both CAV1 and YAP/TAZ allowed us to discrim-
inate between these populations of cells (Figures 5B and S6B).
YAP/TAZ nuclear localization was more pronounced in cells
deficient of CAV1 (Figures 5B and 5C). This shows that the
shCAV1-mediated YAP/TAZ hyperactivity is due to cell-intrinsic
events.
To investigate whether the upregulation ofCYR61 andCTGF in
caveolae-deficient cells was caused by increased YAP/TAZ-
TEAD transcriptional activity, we prepared qPCR samples of
both shCAV1 and shCAVIN1 cells and compared those to
control cells (Figures 5D and 5G). In both shCAV1 and shCAVIN1
cells, an upregulation of YAP/TAZ-TEAD transcriptional activity
was evident. Importantly, nuclear-to-cytoplasmic ratio of YAP/
TAZ, as well as their transcriptional activity, was restored to
WT levels upon re-expression of CAV1 (Figures 5H–5J and
S5E). Together, these data indicate caveolar impact on YAP/
TAZ-TEAD activity.
To probe further the concept of caveolae as regulators of YAP/
TAZ activity, we examined HEK293A cells with knockdown of
CAVIN1 andCAV1. Lowering either CAV1 or CAVIN1 expression
caused markedly increased levels of CYR61 expression (Fig-
ure S5F). We explored whether this increase was due to
transcriptional upregulation and identified that YAP/TAZ target
genes indeed were increased in cells with lowered CAV1 expres-
sion (Figure S5G), as was the case for U2OS cells (Figures 5D
and 5F). This suggests caveolae as an upstream negative regu-
lator of YAP/TAZ. To examine whether this function is conserved
in vivo, we utilized cav1/;cav3/mutant zebrafish, which lack
caveolae [12]. We developed a labeling procedure that allowed
us to examine YAP localization in the epidermis of 48 hr post-
fertilization (hpf) embryos (Figure 6A). There was a clear increase
in the YAP nuclear-to-cytoplasmic ratio in cav1/;cav3/
mutant embryos compared to WT (Figures 6A and 6B). As
YAP/TAZ mutant embryos do not survive until 48 hpf [34] andFigure 4. YAP/TAZ Activity Dictates Caveolar Protein Levels
(A) Dot plots of in silico bioinformatics analysis of data obtained from cancer cell
strong positive correlation between established YAP/TAZ target genes (CYR61 an
no correlation for HPRT1 or for another endolysosomal gene, such as FLOTILLIN2
each correlation; p < 0.05; Pearson’s correlation coefficient.
(B) Western blots from YAP KO U2OS cells with stable shRNA-induced knockdo
(C) Western blots from TAZ KO U2OS cells with stable knockdown of YAP or co
(D) Western blots from NF2 KO and WT U2OS cells (Figure S5B).
(E and F) Confocal image of U2OS WT (E) and NF2 KO cells labeled for YAP/TAZ
(G) Dot blots of nuclear-to-cytoplasmic ratio of YAP/TAZ, quantified of images a
(H) Cell lysates from WT, NF2 KO cells exogenously re-expressing NF2, or NF2 K
(I) Lysates, as in (H), separated on a conventional SDS-gel and processed for we
(J) qPCR data fromNF2 re-expressors, relative to NF2KOU2OS control cells. NF2
(K) qPCR data from NF2 KO U2OS shTEADs relative to control cells. TEAD k
(Figures S5B and S5C).
(L) Micrographs from epidermis cells from WT zebrafish embryos. Arrows: exam
(M) Micrographs from epidermis cells from mutant (yap/:taz/) zebrafish emb
(N) Quantification of caveolae from micrographs; each dot represents data from
(O) qPCR analysis of zebrafish from 5 embryos of each genotype. Means ± SD.
8 Current Biology 29, 1–14, January 21, 2019we therefore could not fully verify our YAP antibody specificity
at this developmental stage, we furthermore utilized a GFP-
tagged, TEAD-binding-deficient YAP construct (GFP-YAP-
S54A), expressed from an epithelial promoter, and introduced
it into cav1/;cav3/ mutant and WT embryos. This YAP
mutant construct was co-expressed with H2A-mCherrry to allow
for visualization of the nucleus (Figure 6C). In the fish embryos,
we measured a significant increase in YAP nuclear to cyto-
plasmic localization in cav1/;cav3/ compared to WT
(Figures 6C and 6D). Moreover, we examinedwhether the human
TEAD-binding-deficient YAP counterpart (YAP-S94A) was sensi-
tive to well-known YAP stimuli, such as serum stimulation [23],
which was indeed the case (Figure S5H). The co-expression of
GFP-YAP-S54A and H2A-mCherry in the embryos therefore
allowed us to validate our endogenous embryonic YAP
labeling data (Figures 6A–6D). In addition, embryos from
cav1/;cav3/ mutants were compared to WT and we
observed a marked increase in cyr61 and ctgf expression (Fig-
ure 6E). Cumulatively, these data demonstrate YAP/TAZ-TEAD
activity is augmented upon caveolae deficiency, and this effect
is conserved across species and in vivo.
Caveolae Facilitate YAP/TAZ-Mediated Flow Response
As both caveolae [9] and the Hippo pathway [36–38] mediate
cellular responses from shear stress, we set out to examine
whether caveolae and the Hippo pathway are mechanistically
linked in this process. We prepared cell lysates from confluent
WT HEK293A cells grown under a range of constant flow rates
(0–4.73 105 Dyn/cm2) for 18 hr and analyzed YAP/TAZ activity.
Specifically, we measured the phosphorylation status of YAP
and the expression of CYR61 and compared these cells to Y/T
KO cells grown under shear stress. We identified a flow-depen-
dent increase in YAP/TAZ activity, as noted by the dephosphor-
ylation of YAP (Figure 7A), and increased protein expression of
TAZ and CYR61 (Figure 7B). As 2.13 105 Dyn/cm2 is sufficient
to activate YAP/TAZ (Figures 7A and 7B), and well within the
range of physiological shear stress [39, 40], we chose this level
for the remaining shear stress experiments. As expected, YAP
nuclear localization (Figures 7C and 7D) and transcription of
CYR61 and CTGF were increased in cells that had experiencedline encyclopedia (CCLE) in cell lines from 967 subjects. The analysis revealed
d CTGF) as well as betweenCYR61 and CAV1 or CAVIN1. However, there was
(FLO2), serving as negative controls (Figure S5A). R values were calculated for
wn of TAZ or control (Figure S5D).
ntrol (Figure S5D).
(green) and DAPI (blue; F). Scale bars represent 20 mm.
s in (E) and (F). Each dot represents one cell. Means ± SEM.
O control cells were separated in a PhosTag gel and probed for YAP.
stern blotting.
re-expression reduces expression ofCYR61,CAV1, andCAVIN1. Means ± SD.
nockdown reduces expression of CYR61, CAV1, and CAVIN1. Means ± SD
ples of caveolae at the plasma membrane.
ryos show no caveolae. Scale bars in (L) and (M) represent 500 nm.
one fish embryo. Means ± SEM.
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Figure 5. CAV1 Is a Negative Regulator of YAP/TAZ
(A) Western blot analysis of shRNA-induced CAV1 knockdown or control U2OS cells. Note higher expression of CTGF and CYR61 in CAV1 knockdown cells.
(B) Confocal image of mixed cell population of shCAV1 and shCon cells labeled for YAP/TAZ (green), CAV1 (red), and DAPI (blue; Figures S6A and S6B). Arrows:
examples of shCAV1 cells. Scale bar represents 20 mm.
(C) Dot plots of quantification of nuclear-to-cytoplasmic ratio of YAP/TAZ from images as in (B). Each dot represents one cell. Means ± SEM.
(D) qPCR analysis of shCAV1 cells. Means ± SD.
(E) Western blots from U2OS shCon and shCAV1 cell lysates from three independent experiments (nos. 1–3).
(F) Quantification from blots in (E) of normalized CYR61 values in U2OS shCAV1 cells compared to shCon cells. Student’s t test. Means ± SEM; shCAV1 cells have
higher levels of CYR61 than control cells.
(G) qPCR analysis of shCAVIN1 U2OS cells compared to control. Means ± SD.
(H) Confocal image of mixed cell population of shCAV1 (empty vector) and shCAV1 (CAV1-GFP re-expressor) cells, labeled for YAP/TAZ (red), GFP (green), and
DAPI (blue). Re-expression of CAV1 in shCAV1 cells rescues hyperactivation of YAP (related to Figures S5E, S6D, S6E, S6I, and S7D–S7K). Scale bar represents
10 mm.
(I) Dot plot of quantification of nuclear-to-cytoplasmic ratio of YAP/TAZ from images as in (E). Each dot represents one cell. Means ± SEM.
(J) qPCR analysis of CAV1-GFP-expressing shCAV1 cell line compared to control shCAV1. Means ± SD.
Further related to this figure are Figures S5G and S5F.
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Figure 6. CAVEOLINs Are Negative Regulators of YAP/TAZ In Vivo
(A) Images of epithelial cells from WT and cav1//cav3/ 48 hpf zebrafish embryos labeled for Hoechst (blue) and YAP (red). Note the increased nuclear YAP
localization in cav1//cav3/ cells. Scale bars represent 25 mm.
(B) Quantification of cellular nuclear-to-cytoplasmic ratio from cav1//cav3/ superficial epidermal cells compared to WT. Each dot represents one cell.
n > 100. Means ± SEM.
(C) Images from cav1//cav3/ and WT zebrafish embryos expressing epidermal EGFP-yap S54A (Tead-binding-deficient zebrafish yap mutant) and H2A-
mCherry (nuclear marker). Note the predominantly nuclear YAP localization in the cav1//cav3/ epidermal cells compared toWT. Scale bars represent 20 mm.
(D) Quantification of nuclear-to-cytoplasmic ratio from cav1//cav3/ epidermal cells compared to WT. Each dot represents one cell. n > 50 from each ge-
notype. Means ± SEM (related to Figure S5H).
(E) qPCR analysis from four-day-old cav1//cav3/ and WT zebrafish embryos. Means ± SD.
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Current Biology (2018), https://doi.org/10.1016/j.cub.2018.11.066shear stress (Figure 7E). The induction of the YAP/TAZ target
CYR61 upon flow is therefore a suitable assay to study the
shear-stress-mediated regulation of the Hippo pathway. To
examine whether the activation of YAP/TAZ upon flow is medi-
ated via caveolae, we asked whether the flow-mediated induc-
tion was different between WT cells and cells with reduced
CAV1 expression levels. It was apparent that the fold induction
of CYR61 protein expression upon flow was markedly reduced
(by 40%) in shCAV1 cells (Figures 7F, 7G, and S6F). Indeed, in
cells with efficient reduction of CAV1, the shear-stress-mediated
induction of YAP/TAZ activity was diminished, as determined by
the mRNA levels ofCTGF andCYR61 (Figure 7H). To further gain
insights into the underlying mechanisms and establish whether
this process was mediated via paracrine factors, we generated
CAV1 KO cells (Figures S6G, S6H, and S7A–S7C). By a mixed
cell culture assay, we determined the localization of YAP in
CAV1 KO and WT cells. YAP was more nuclear at steady state
in CAV1 KO cells (Figure 7I), and the flow-induced nuclear trans-
location of YAP was decreased in CAV1 KO cells compared to
WT cells (Figure 7J). Furthermore, shear stress induced an in-
crease of the YAP/TAZ-TEAD target genes CTGF and CYR61
to a higher extent in WT compared to the CAV1 KO cells (Fig-
ure 7G). Importantly, the re-introduction of CAV1 into CAV1 KO
cells rescued this phenotype (Figures S6I and S7D–S7M).10 Current Biology 29, 1–14, January 21, 2019CAV1 deficiency in L1/L2 KO did not further increase YAP/TAZ
activity levels (Figures S7N–S7R), consistent with saturated
YAP/TAZ activity in L1/L2 KO cells (Figures 1C–1G, S1F, and
S2E) [6, 7]. These data show that YAP/TAZ are activated upon
shear stress, that YAP/TAZ are hyperactivated in cells without
caveolae, and that shear-stress-mediated activation of YAP/
TAZ is facilitated by caveolae.
DISCUSSION
The Hippo pathway is recognized as critical for multiple cellular,
developmental, and homeostatic processes [1–5]. Due to its
central role in many biological contexts, tight regulation of this
pathway is required and a variety of feedback mechanisms
have evolved [7, 35]. In this study, we find reciprocal relation-
ships between caveolar function and Hippo signaling. Specif-
ically, we show that YAP/TAZ-TEAD activity directly regu-
lates transcription of components that comprise caveolae.
Conversely, loss of caveolae results in Hippo kinase cascade
inactivation and thus increased YAP/TAZ-TEAD activity.
Flow sensing playsmajor roles inmultiple cell types, especially
during development [39, 40], in the cardiovascular system [40], in
the kidney [39], and elsewhere [41]. The transduction of shear
stress into cells has previously been shown to depend, at least
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Figure 7. Caveolae Facilitate YAP/TAZ-
Mediated Flow Response
(A) Confluent HEK293A cells were kept in cham-
bers with different flow speeds for 18 hr. YAP/TAZ
KO cells were kept at high flow only. Western blot
of cell lysates separated on a PhosTag gel and
probed for YAP is shown. Note the dephosphor-
ylation (downshift of YAP) and therefore predicted
activation of YAP upon flow.
(B) Western blots of cell lysates as in (A). Note the
increase in CYR61 protein upon flow in WT cells.
(C) Confocal images of cells grown without () or
with flow at 2.1 3 105 Dyn/cm2 (+). Cells labeled
for YAP (green) and CAV1 (red) are shown. Scale
bar represents 20 mm.
(D) Dot plot representing quantification of nuclear-
to-cytoplasmic ratio of YAP/TAZ localization from
images as in (C). Each dot represents one cell.
Means ± SEM.
(E) qPCR analysis of HEK293A WT cells kept at
either 0 or 2.13 105 Dyn/cm2. CTGF and CYR61
mRNA were increased upon flow. Means ± SD.
(F) Western blot of cell lysates from either control
or shCAV1 cells kept at either 0 ( flow) or at 2.13
105 Dyn/cm2 (+ flow). Note induction of CYR61
upon flow inWT cells (related to Figures S5F, S5G,
and S6F).
(G) Quantification of CYR61 levels from western
blots as in (F), normalized to HSP90 levels. n = 3;
means ± SD.
(H) Relative fold induction of target gene expres-
sion in shCAV1 upon flow compared to control
cells. Means ± SD.
(I) Dot plots of YAP localization from images of
cells at steady state. Each dot represents one cell.
Means ± SEM.
(J) Dot plots of normalized values of flow-induced
(2.1 3 105 Dyn/cm2) YAP nuclear localization.
Each dot represents one cell. Means ± SEM.
(K) Relative fold induction of target gene expres-
sion in two separate CAV1 KO clones upon flow
was compared to control cells. Means ± SD. Flow-
mediated induction of CTGF and CYR61 is CAV1
dependent.
Further related to this figure are Figures S6G, S6H,
and S7A–S7C.
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Current Biology (2018), https://doi.org/10.1016/j.cub.2018.11.066in part, on caveolae [9, 11]. Still, hitherto how caveolae mediate
flow sensing and other types of mechanotransduction to the
interior of the cell is not well understood [9–14]. Related, shear
stress and other mechanical perturbations can affect Hippo
signaling [8, 36–38]. Mechanistic insights into how the Hippo
pathway is regulated by shear stress and how this cellular
response is conferred has been limited [36–38]. We observed
an upregulation of the matricellular remodeling factors CTGF
and CYR61 with increased fluid flow. Notably, we identified
that the induction of these YAP/TAZ-TEAD-dependent target
genes [24] by shear stress is partly caveolae dependent.
Although a complete understanding of this process remains to
be determined, we show that shear stress transduction medi-
ated by caveolae is regulated via LATS-mediated inhibitoryphosphorylation of YAP/TAZ. Upon shear stress, the caveolae-
facilitated activation of the Hippo kinase cascade is blunted.
Consequently, caveolae-depleted cells are less sensitive to
shear-stress-mediated YAP/TAZ activation. As caveolae are
known to buffer cells frommechanical stress [9–14, 42], the feed-
forward upregulation of caveolar components by YAP/TAZ may
represent a protective response.
The connection between caveolar function and Hippo
signaling may extend beyond transduction of shear stress. For
example, both caveolae and the Hippo pathway also play central
roles in metabolic signaling [19, 22, 43, 44], regeneration [45, 46],
and cancers [1, 17]. One aspect that merits highlighting is that
loss-of-function mutations within the muscle-specific caveolin
isoform CAV3 [47] or CAVIN1 [48] causes muscular dystrophy.Current Biology 29, 1–14, January 21, 2019 11
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and intriguingly, there are overlapping gene sets between those
upregulated in muscular dystrophy, caused by CAVIN1 or CAV3
mutations, and those driven by deregulation of muscular YAP/
TAZ-TEAD transcription [48–51]. It might therefore be worth
pursuing to examine the state of the Hippo pathway within
caveolae-deficient muscular dystrophy patients. Targeting the
Hippo pathway within these patients may allow for therapeutic
intervention [1–5]. It is noteworthy that the decrease of caveolar
proteins is very dramatic upon YAP/TAZ loss of function,
whereas overexpression of YAP/TAZ only modestly increases
CAV1 andCAVEOLIN1. It thus appears that YAP/TAZ are essen-
tial but might not be sufficient to drive expression of caveolar
genes in all scenarios. We anticipate that additional factors regu-
lating nuclear YAP/TAZ-TEAD activity, such as VGLL4 [52],
MRTF-SRF [53, 54], AP1 [55, 56], and SWI/SNF [57, 58], might
also play a role in regulating caveolar gene expression. The
direct and reciprocal link between caveolae and the Hippo
pathway provided here paves the way for further explorations
into the biology of these little caves and this potent signaling
pathway.
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Antibodies
Anti-YAP Santa Cruz Biotechnology Cat# sc-101199, RRID:AB_1131430
Anti-YAP Proteintech Group Cat# 13584-1-AP, RRID:AB_2218915
Anti-CYR61 Santa Cruz Biotechnology Cat# sc-13100, RRID:AB_2088733
Anti-CTGF Santa Cruz Biotechnology Cat# sc-14939, RRID:AB_638805
Anti-GAPDH Santa Cruz Biotechnology Cat# sc-25778, RRID:AB_10167668
Anti-CAV1 BD Biosciences RRID:BD610060
Anti-CAV2 BD Biosciences RRID:BD610684
Anti-HSP90 BD Biosciences Cat# 610418, RRID:AB_397798
Anti-panTEAD Cell Signaling Technology Cat# 13295, RRID:AB_2687902
Anti-YAP p127 Cell Signaling Technology Cat# 4911S, RRID:AB_2218913
Anti-YAP p397 Cell Signaling Technology Cat# 13619, RRID:AB_2650554)
Anti-NF2 Cell Signaling Technology Cat# 6995S, RRID:AB_10828709
Anti-LATS1 Cell Signaling Technology Cat# 3477, RRID:AB_2133513
Anti-LATS2 Cell Signaling Technology Cat# 5888, RRID:AB_10835233
Anti-CAVIN1 Cell Signaling Technology RRID:Cat# 69036
Anti-YAP Abcam Cat# ab52771, RRID:AB_2219141
Anti-CAVIN1 Abcam Cat# ab48824, RRID:AB_882224
Anti-GFP Abcam Cat# ab6556, RRID:AB_305564
Anti-CAVIN3 Bethyl Cat# A302-419A, RRID:AB_1907302
Anti-CAVIN2 Atlas Antibodies Cat# HPA039325, RRID:AB_10805473
Anti-CAV1 Jørgen Vinten, University
of Copenhagen
See [59]
Anti-Myc Cell Signaling Technology RRID:Cat# 2276
Anti-mouse IgGs Fisher scientific RRID:Cat#12102270
Anti-rabbit IgGs Fisher scientific RRID:Cat#1805935
Anti-TEAD1 BD Biosciences Cat# 610923, RRID:AB_398238
Anti-Goat Immunoglobulins/HRP DAKO RRID:P044901
Anti-Rabbit Immunoglobulins/HRP DAKO RRID:P044801
Anti-Mouse Immunoglobulins/HRP DAKO RRID:P044701
Goat anti-Rabbit IgG (H+L) Cross-Adsorbed
Secondary Antibody, Alexa Fluor 488
Thermo Fisher Scientific Cat# A-11008, RRID:AB_143165
Goat anti-Rabbit IgG (H+L) Highly Cross-
Adsorbed Secondary Antibody, Alexa Fluor 594
Thermo Fisher Scientific Cat# A-11037, RRID:AB_2534095
Goat anti-Mouse IgG (H+L) Highly Cross-
Adsorbed Secondary Antibody, Alexa Fluor 594
Thermo Fisher Scientific Cat# A-11032, RRID:AB_2534091
Goat anti-Mouse IgG (H+L) Highly Cross-
Adsorbed Secondary Antibody, Alexa Fluor 488
Thermo Fisher Scientific Cat# A-11029, RRID:AB_2534088
Goat anti-Rabbit IgG (H+L) Highly Cross-
Adsorbed Secondary Antibody, Alexa Fluor 633
Thermo Fisher Scientific Cat# A-21071, RRID:AB_2535732
Bacterial and Virus Strains
Dh5-alpha E.coli Sonja Vermeren, University
of Edinburgh
N/A
One Shot Stbl3 Chemically Competent E. coli Life Technologies C737303
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Chemicals, Peptides, and Recombinant Proteins
Verteporfin Sigma-Aldrich SML0534-5MG
Puromycin VWR CAYM13884
G418 Scientific Laboratory
Supplies Ltd
G5013
Hygromycin B Scientific Laboratory
Supplies Ltd
30-240-CR
GeneJet DNA transfection reagent Tebu-Bio 189SL100488
LIPOD293 DNA transfection reagent Tebu-Bio 189SL100668
DMEM GIBCO 21969-035
FBS, heat inactivated GIBCO 10500-064
Glutamine GIBCO 25030-024
Penicillin/Streptomycin GIBCO 15140-122
Immuno Western ECL mix millipore WBKLS0500
Antifade citifluor AF1-100
DMSO Sigma D2650
ProLong Diamond Antifade Mountant with DAPI Thermo Fisher Scientific P36962
Hoechst Thermo Fisher Scientific 3342
Formaldehyde Solution, Methanol free Thermo Fisher Scientific 28908
Polyacrylamide Thermo Fisher Scientific BP1408-1
Critical Commercial Assays
RNeasy plus mini kit QIAGEN 74136
High-capacity cDNA reverse transcriptase kit Applied biosciences 4368814
Brilliant III Ultra-fast SYBR Green QPCR Master Mix Agilent Technologies 600883
Dual-Glo luciferase assay system Promega E2920
ChIP-IT Express Enzymatic kit Active Motif Inc. 53009
DNA Clean & Concentrator-5 Zymo Research D4003T
Experimental Models: Cell Lines
HEK293A Kun-Liang Guan lab, UCSD N/A
HEK293T Kun-Liang Guan lab, UCSD N/A
U2OS Jack Dixon, UCSD N/A
Experimental Models: Organisms/Strains
wwtr1 mutant zebrafish Link Lab, Medical College
of Wisconsin
Allele mw49
yap1 mutant zebrafish Link Lab, Medical College
of Wisconsin
Allele mw48
cav1 mutant zebrafish Poss Lab, Duke University Allele pd1104
cav3 mutant zebrafish Bagnat Lab, Duke University Allele pd1149
Oligonucleotides
Please refer to Tables S1 and S2 N/A N/A
Recombinant DNA
Please refer to Table S3 N/A N/A
Software and Algorithms
Fiji ImageJ https://fiji.sc/
Prism GraphPad https://www.graphpad.com/
scientific-software/prism/
Photoshop and InDesign Adobe https://www.adobe.com/uk/
creativecloud.html
Excel and Word Microsoft https://www.office.com/
BioRender BioRender https://app.biorender.io/
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Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
Other
Quasi Vivo QV500 system Kirkstall QV500
PF22X0103 peristaltic pump Parker PARKER PF22X0103
Thermanox 13mm coverslips Thermo Fisher Scientific #174950
LightCycler 96 System Roche N/A
X Ray Film 18x24cm Double Sided Scientific Laboratory Supplies Ltd MOL7016
ThermanoxTM 13 mm coverslips Thermo Fisher Scientific #174950
COVER GLASS ROUND Ø 13 MM NO.1 VWR International Ltd. 631-1578
Immobilon(R)-P Polyvinylidene difluoride
membranes,size 26.5 cm x 375 cm
Sigma-Aldrich P2938-1ROL
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Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Carsten
G. Hansen (Carsten.g.hansen@ed.ac.uk).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
In vitro studies: cell lines
All cell lines were cultivated at 37C in a humidified, 5% CO2 atmosphere. HEK293A, HEK293T, and U2OS cells were cultivated in
high glucose DMEM (GIBCO) supplemented with penicillin, streptomycin, 2 mM glutamine, and 10% fetal bovine serum (FBS) if
nothing else stated.
The HEK293A and HEK293T cell line are human epithelial cells originating from embryonic kidney of a female. The wild-types (WT)
as well as the HEK293A YAP/TAZ, and LATS1/2 double knockout cell lines [22, 35] were kindly provided by Professor Kun-Liang
Guan lab, University of California, San Diego (UCSD). HEK293A cell lines were used to perform experiments while HEK293T cells
where used for virus generation. The U2OS cell line originates from human epithelial from the bone of a female suffering from
osteosarcoma. The U2OS wild-type was kindly provided to us by Professor Jack Dixon (UCSD). Cells were periodically tested for
Mycoplasma contamination but were not authenticated.
In vivo studies: zebrafish
Danio rerio (ZDR strain) were raised and housed in amulti-rack Pentaire aquatics systemusingwater purified by high capacity reverse
osmosis coupled with mechanical and biological filtration. The room maintained at 28.5C and under a 14 hr light / 10 hr dark cycle.
Zebrafish were not immunized, but the colony was routinely screened for the following pathogens. All specimens were negative the
pathogens assayed: Edwardsiella ictaluri, Flavobacterium columnare, Ichthyophthirius multifiliis, Infectious spleen & kidney necrosis
virus (ISKNV), Mycobacterium spp., Mycobacterium abscessus, Mycobacterium chelonae, Mycobacterium fortuitum, Mycobacte-
rium haemophilum, Mycobacterium marinum, Mycobacterium peregrinum, Myxidium streisingeri, Piscinoodinium pillulare, Pleisto-
phora hyphessobryconis, Pseudocapillaria tomentosa, Pseudoloma neurophilia The embryoswere harvested at early developmental
stages (at the latest 48 hpf) and were not sex matched. Subjects were naive and not previously involved in other procedures prior to
the experiments reported here.
The following lines were used to generate yap;taz (wwtr1) double homozygous mutants.
yap1mw48 (c. 158-161del). This allele has a 4 bp deletion within exon1 [34].
wwtr1mw49 (c. 156-160del). This allele has a 5 bp deletion within exon1 [34].
In addition, cav1;cav3 double homozygous mutants have been described elsewhere [12]. All experiments involving zebrafish were
performed in compliancewith the Institutional Animal Care andUseCommittee of theMedical College ofWisconsin, protocol number
AUA1378.
METHOD DETAILS
Generation of knockdown (KD), knockout (KO), and re-expression cell lines
KD cell lines were generated by retrovirus mediated shRNA knockdown. The virus was generated by co-transfecting pMD2G
and pSPAX2 (from the Kun-Liang Guan lab, UCSD) with pKLO.1-vectors coding for shRNAs mediated targeting of YAP
(TRCN0000300325), TAZ (TRCN0000370007), and TEADs 1/3/4 as previously described [22, 24], or CAV1 TRCN0000008002Current Biology 29, 1–14.e1–e6, January 21, 2019 e3
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The virus was harvested, filtered and added to polybrene treated cells of interest. Following 6-8 hr incubation the cell medium was
changed. Stable cell lines were generated following puromycin selection. To generate U2OS CAV1 re-expressing cell lines, shCAV1
cells were transfected with CAV1-GFP plasmid (#14433, Addgene) and stable exogenous CAV1-expressing cells were established
by G418-selection (SLS). Plasmids encoding either WT or mutant YAP (S94A or 5SA) as well as WT or mutant TAZ (S51A) are listed in
Table S3 [24, 27]. HEK293A CAV1 re-expressing cell lines were generated by lentiviral transduction of CAV1 KO cells with a pBabe
vector carrying the open reading frame of human CAV1. Clonal YAP and TAZ (WWTR1) knock-out cell lines were generated by tran-
sient transfection of CrispR constructs, followed by two days of puromycin selection and one day recovery in medium without pu-
romycin, followed by single cell sorting into 96-well plates [22]. To generate CrispR-mediated CAV1 KO cell lines, the following
oligo nucleotides were ligated and thereafter inserted into pSpCas9(BB)-2A-Puro (PX459 V2.0; Addgene plasmid #48139):
CAV1crispr#1fw CACCGAGTGTACGACGCGCACACCA, CAV1crispr#1rev AAACTGGTGTGCGCGTCGTACACTC and CAV1
crispr#2fw CACCGTTTAGGGTCGCGGTTGACC, CAV1crispr#2rev AAACGGTCAACCGCGACCCTAAAC. Cells were transfected
using LipoD293 or GenJet transfection reagent (SignaGen Laboratories). CrispR oligos are listed in Table S2.
Transformation
Transformation of competent bacteria was carried out by heat shock, where after bacteria were seeded onto selective Petri dishes.
The following day single clones were picked and propagated for plasmid harvest.
Western blotting
Cell lysate preparation in reducing lysis buffer and western blotting was performed as described in Hansen et al., 2015 [22] using the
following antibodies against YAP/TAZ (sc101199), CYR61 (sc13100), CTGF (sc14939), and GAPDH (sc25778) all from Santa Cruz as
well as CAV1 (BD610060), CAV2 (BD610684), and HSP90 (BD610418) from BD Biosciences, pan TEAD (3295), pYAP 127 (4911),
pYAP 397 (13619), NF2 (Merlin, 6995), LATS1 (3477), LATS2 (5888), and CAVIN1 (PTRF, 69036) from Cell Signaling Technology,
and YAP (ab52771), CAVIN1 (PTRF, ab48824) (only used for western blotting in this study), and GFP (ab6556) from Abcam.
Antibodies against CAVIN3 (SRBC, A302-419A) were from Bethyl laboratories and against CAVIN2 (SDPR, HPA039325) were
from Sigma. Monoclonal antibodies raised against CAV1 were provided by Jørgen Vinten [59] (The Panum Institute, University of
Copenhagen). Furthermore, HRP-conjugated secondary antibodies were used for western blotting.
Besides conventional SDS gels western blotting was performed with Phos-Tag gels. Therefore, 15 mL Phos-tag reagent (Wako
chemicals) and 25 mL of 10mM MnCl2 were added to each 7.5% (w/v) polyacrylamide gel while the subsequent steps remained
the same. Blots were developed using ImmunoWestern ECL mix (Millipore) and X-ray films (SLS). A larger area of the scans of west-
ern blot films is shown in Data S1.
RT-qPCR and Primers
For quantitative reverse transcription PCR (RT-qPCR)mRNAwas extracted from cells using the RNeasy plusmini kit (QIAGEN). Com-
plementary DNA (cDNA) was generated using High-Capacity cDNA Reverse Transcriptase kit (Applied Biosystems). qPCR was
performed on 1 ng of cDNA using the Brilliant III Ultra-Fast SYBRGreen QPCRMaster Mix (Agilent Technologies) and the LightCycler
96 System (Roche) according to manufactures instruction. In mammalian cells expression levels of all genes analyzed were
normalized to Hypoxanthine-guanine phosphoribosyltransferase (HPRT1) levels [22]. Primer sets against caveolar components
were designed using primerbank [60]. qPCR primers, harvest of samples and preparation of cDNA from zebrafish embryos were car-
ried by establishedmethods [34, 42]. Samples were normalized to Elongation factor 1-alpha (ef1a) [34]. Primers are listed in Table S1.
Chromatin immunoprecipitation qPCR (ChIP-qPCR)
ChIP was performed on HEK293A WT cells using the ChIP-IT Express Enzymatic kit (Active Motif Inc.). For immunoprecipitation
anti-mouse IgGs (whole molecule, #12102270, Fisher Scientific), anti-rabbit IgGs (whole molecule, #11805935, Fisher Scientific),
anti-TEF-1 (TEAD1, #610923, BD Bioscience), and anti-YAP (ab52771, Abcam) antibodies were used. Subsequent DNA clean up
(by DNA Clean & Concentrator-5, Zymo Reseach) was followed by DNA quantification by qPCR analysis and output was normalized
to the input DNA. Primer sequences are as follows 50-TGGCATAACCTGTTGGCATA-30 and 50-CCCAAACGCTTCGAAATAAG-30
(forward and reverse) CAV1 promoter (CAV1), 50-TTTCAGAATCTCCTGGTCCAC-30 and 50-TTGCTCTCTGTTTCCCTCTC-30 CAVIN1
promoter (CAVIN1), 50-CCTCCGTGTCTCAGTGGTTT-30 and 50-TCACCTTGCTTGCCTTTCTT-30 CAV1 in gene (CAV1 Ing), and
50-GCAGTTTTGAGGAGGCAAAG-30 and 50-AAATGCTTCCTGGCCCTTAT-30 CAVIN1 in gene (CAVIN1 Ing) and CTGF was used
as a control [22].
Immunofluorescence (IF) Microscopy
Cells were seeded onto poly-D-lysine (Sigma) coated coverslips, fixed with 37C 4% formaldehyde (Sigma) (v/v in PBS), permeabi-
lized and incubated in IF buffer (2.5% FBS, 0.3% Triton-x-100 (v/v) in PBS) with antibodies listed above, washed and subsequently
incubated with fluorophore-conjugated secondary antibodies (Thermofisher). Cells on the coverslip were mounted on glass slides
using ProLong Diamond Antifade Mountant with DAPI stain (Thermofisher). This procedure is described in more detail in [61]. Image
acquisition was performed by a Zeiss 780 inverted confocal laser scanningmicroscope (CLSM) utilizing a Plan-Apochromat 633 /1.4
Oil DIC M27 objective. For quantification of IF images a polygonal region of interest (ROI) was drawn manually and used to quantifye4 Current Biology 29, 1–14.e1–e6, January 21, 2019
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identified in the DAPI channel and used to draw a ROI. Subsequently, the value of this ROI was measured in the channel of interest
and tabulated. The ROI was then moved to the cytoplasm, measured and tabulated. Nucleoli were excluded from ROIs. For quan-
tification of CAV1 or CAVIN1 levels, the confocal plane was selected to be at the base of the cells. ROI of the signal in these images
wasmeasured, and tabulated in Microsoft Excel, depending on the absence or presence of YAP/TAZ, TEAD or CAV1 signal, again by
flicking between channels in Fiji (ImageJ). Cells undergoing mitosis or with multi nuclei, as determined by DAPI stain, were not
included in the quantification. Five to 15 cells of each population, as determined by the presence or absence of signal in the other
channel, were quantified from between 8 - 15 different images. The ratios were calculated in Microsoft Excel and plotted as a scat-
terplot in GraphPad Prism.
Verteporfin treatment
HEK293AWT cells were treated with 6.45 mM verteporfin (Sigma-Aldrich) with 1.87% (v/v) dimethyl sulfoxide (DMSO, Sigma-Aldrich)
and compared to DMSO treated cells. After 18 hr, mRNA was extracted and RT-qPCR was performed [22].
Proximal promoter cloning and luciferase assay
The upstream promoter regions ofCAV1 andCAVIN1were examined for M-CAT and putative TEAD bindingmotifs. pGL3-basic vec-
tors carrying upstream proximal promoter regions of either CAV1 (1907 to +200bp) or CAVIN1 (1250 to +150bp) were generated
by restriction cloning and insertion into themultiple cloning site usingMlu1/Xho1 (CAV1) or Kpn1/Mlu1 (CAVIN1) respectively. A short
version (550 to +200bp) of the CAV1 promoter was also generated, which does not harbor any predicted TEAD recognition sites.
HEK293A YAP/TAZ KO cells were co-transfected with either one of the plasmids above and pCMV Flag-YAP. 36-48 hr after trans-
fection cells were lysed using lysis buffer (91.5 mM K2HPO4, 8.5 mM KH2PO4, 0.2% Triton X-100 (v/v), 1 mM DTT, 1 mM PMFS) and
lysates were transferred into a white 96-well plate (Corning). Luminescence was induced by using the Dual-Glo luciferase assay sys-
tem (Promega) and was detected by a Biotek HT plate reader. Luciferase activity was normalized to renilla signal.
Flow studies
Cells were cultured under laminar flow using the Kirkstall Quasi Vivo QV500 systemwith a Parker (PF22X0103) peristaltic pump. Cells
were seeded onto Thermanox 13mmcoverslips (#174950, ThermoFisher), or (for IF) poly-D-lysine coated glass coverslips and grown
to confluency in complete DMEM containing 10% FBS. The coverslips were transferred into the QV500 system and cells were
cultured in DMEM (with supplements as described above) containing 0.1% FBS and a constant flux of 4.7 and 2.1*105 Dyn/cm2,
respectively. After 18 hr cells were harvested and analyzed by RT-qPCR, western blotting or IF.
Zebrafish Yap localization reporter
Yap localization was assessed specifically in zebrafish epidermal cells by expression of tol2 -4.4kbkrt18:eGFP-YapS54A. Plasmid
DNAwas co-injected with Tol2 transposase aswell as tol2 h2ax:H2A-mCherry plasmid DNA tomark cell nuclei. The YapS54Amutant
(derived from Danio rerio) disrupts Tead factor binding and thus prevents deleterious gain-of-function phenotypes [34]. At 48 hpf,
embryos were fixed in 4% paraformaldehyde for 1 hr and then washed extensively in PBST. Embryos were then mounted in 1%
agarose and imaged using a 40x water-immersion objective on a Nikon C1 scanning laser confocal microscope. Epidermal cells ex-
pressing both eGFP-YapS54A and H2A-mCherry were imaged. For quantifying pixel intensity, image slices with the maximum
nuclear diameter were selected. Total fluorescence intensity was calculated for the entire cell and for just the nucleus by measuring
the eGFP pixel intensity from the corresponding mCherry fluorescence. Cytoplasmic intensity was calculated by subtracting the nu-
clear from total cell measurements. Image acquisition and measurements were obtained in a genotype masked manner. Data pre-
sented are from 50 cells from at least 10 embryos for each genotype.
For whole mount immunohistochemistry fixed zebrafish embryos were washed in PBST and stored in 100% methanol at 20C
overnight. This was followed by rehydration in solution of incrementally increased PBST concentration (25%, 50%, 75% PBST in
methanol) and a final wash in PBST. Subsequently, embryos were incubated in blocking buffer (10% goat serum (Sigma), 0.2%
BSA (Sigma) in PBST) for several hours at room temperature. For labeling of YAP, embryos were left in blocking solution with
anti-YAP antibody (#13584-1-AP, Proteintech) at 4Covernight. After rigorouswashing in PBST, embryos were incubated in blocking
solution containing secondary antibody (Alexa Fluor 633, A21071, Thermofisher), which was followed by another excessive washing
procedure. Nuclei were labeled by Hoechst 3342 (Thermofisher). Finally, embryos were dehydrated in glycerol solutions (30%, 50%,
80% glycerol/PBS) and stored in antifadent (AF1, Citifluor). Labeled zebrafish embryos were mounted in antifadent onto glass slides
andmicroscopic imageswere taken using the Leica SP8CLSMutilizing a HCPL APO 40x oil CS2 objective. A single plane imagewas
taken for image analysis. The nuclear to cytoplasmic ratio was quantified in epidermal cells where Hoechst signal (nuclear diameter)
was the widest. The nuclear to cytoplasmic YAP ratio in individual cells from at least five separate images from each genotype was
plotted in Prism (GraphPad).
Transmission Electron Microscopy (EM)
Zebrafish embryos were collected at the 12 somite stage. Briefly, the blocks were trimmed on a Leica RM2255microtome, and ultra-
thin sections were cut and collected on coated grids, and stained with uranyl acetate and lead citrate [62]. For each embryo, twenty
non-overlapping images of epidermis were captured on a Hitachi H600 at 30,000x. Caveolae within the epidermis were quantified forCurrent Biology 29, 1–14.e1–e6, January 21, 2019 e5
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QUANTIFICATION AND STATISTICAL ANALYSIS
Data is represented with significance values (p) used by ‘‘*’’ p < 0.05, ‘‘**’’ p < 0.01 and ‘‘***’’ p < 0.001. All data originated from at least
three independent biological replicates if not directly stated otherwise. Data was analyzed using Fiji (ImageJ), Excel (Microsoft) and
Prism (GraphPad) software. All statistical analysis and graphs were generated using Prism software. No optimal sample-size estima-
tion was calculated. The genotype of samples imaged in Figures 4L and 4M were blinded for the person quantifying the number of
caveolae. For IF based quantification random images of areas of the coverslips were captured. Cells that had multiple nuclei, were
not optimal processed or were undergoingmitosis were not included. All IF based scatterplots were tested and analyzed by unpaired
Student’s t test, whereas all other data was analyzed using Mann-Whitney, if not stated otherwise. Data are represented as mean ±
standard error of the mean (SEM) or standard deviation (SD) as highlighted in figure legends. For correlation analysis, gene
expression data across a panel of 967 cancer cell lines were downloaded from the Cancer Cell Line Encyclopedia (CCLE) [30]
and the correlations between mRNA expressions of each pair of genes were evaluated by Pearson’s correlation coefficient (r)
with two tailed p values, < 0.05 considered significant.e6 Current Biology 29, 1–14.e1–e6, January 21, 2019
